Berberine, Zinc, and Quercetin in the Context of Rising Consumer Interest in Natural GLP-1 Support and Non-Prescription ...
Independent Analysis Examines ColonBroom GLP-1 Booster Ingredient Transparency, Non-Prescription Supplement Category Context, ...
Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...
Sedentary lifestyles, poor sleep, stress, and ultra-processed diets are driving hormonal inflammation in young adults. A ...
Experts emphasized that obesity is a chronic, relapsing condition and lifelong therapy—in some form—will be necessary.
A clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, with research and development operations ...
Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...
Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...
People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and ...
“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...
News Medical on MSN
Weight Loss Drug Users at Risk of Deficiencies: Experts
People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss ...
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback